MedTrace Logo

Vitamin D Binding Protein (Gc) Allele Variation Effects Response to Vitamin D Treatment

NCT00650780 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 29

Last updated 2008-04-02

No results posted yet for this study

Summary

We have just completed a randomized, clinical trial of 100,000 IU Vitamin D3 given as a single dose at the beginning of winter. We found a wide range of responses to the dose. This study proposes that genetic differences account for some of the variation in response of 25(OH)D levels after treatment with oral Vitamin D.

Conditions

  • Vitamin D Status

Sponsors & Collaborators

  • Creighton University

    lead OTHER

Principal Investigators

  • Laura Armas, MD · Creighton University

Eligibility

Min Age
19 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2008-01-31
Completion
2008-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00650780 on ClinicalTrials.gov